| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 15 | 0 | 0 | 15 |
| Chain A, Cruzipain | 8 | 0 | 0 | 8 |
| regulator of G-protein signaling 4 | 8 | 0 | 0 | 8 |
| Platelet-activating factor receptor | 0 | 3 | 0 | 3 |
| Inositol monophosphatase 1 | 8 | 0 | 0 | 8 |
| TDP1 protein | 26 | 0 | 0 | 26 |
| AR protein | 34 | 0 | 0 | 34 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 17 | 0 | 0 | 17 |
| glucocorticoid receptor [Homo sapiens] | 26 | 0 | 0 | 26 |
| estrogen nuclear receptor alpha | 38 | 0 | 0 | 38 |
| nuclear receptor subfamily 1, group I, member 2 | 10 | 0 | 0 | 10 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform 2 | 28 | 0 | 0 | 28 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 24 | 0 | 0 | 24 |
| 60 kDa chaperonin | 0 | 4 | 0 | 4 |
| 60 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
| 60 kDa chaperonin | 0 | 4 | 0 | 4 |
| 10 kDa chaperonin | 0 | 4 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 15 | 0 | 0 | 15 |
| Ataxin-2 | 16 | 0 | 0 | 16 |
| Protein skinhead-1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 31 | 0 | 0 | 31 |
| lamin isoform A-delta10 | 18 | 0 | 0 | 18 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Putative glycosyltransferase WbgO | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 6 | 0 | 6 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Killer cell lectin-like receptor subfamily B member 1A | 0 | 1 | 0 | 1 |
| Early activation antigen CD69 | 0 | 1 | 0 | 1 |
| Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
| Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
| Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
| Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 2 | 2 |
| ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
| Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
| 2-dehydropantoate 2-reductase | 0 | 2 | 2 | 4 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
| Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
| Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
| Endoplasmin | 0 | 0 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| 5'-nucleotidase | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 4 | 1 | 5 |
| Delta-type opioid receptor | 0 | 0 | 1 | 1 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| P2Y purinoceptor 2 | 0 | 0 | 2 | 2 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 2 | 2 |
| P2Y purinoceptor 1 | 0 | 0 | 2 | 2 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
| Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 11 | 0 | 0 | 2 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
| Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
| P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
| Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 27 | 0 | 0 | 27 |
| euchromatic histone-lysine N-methyltransferase 2 | 21 | 0 | 0 | 21 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 17 | 0 | 0 | 17 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 5 | 0 | 6 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 4 | 0 | 4 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 0 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 2 |
| GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 2 | 6 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
| Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
| Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
| Protease | 0 | 1 | 1 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 2 |
| ATP-dependent phosphofructokinase | 12 | 0 | 0 | 12 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| Luciferase | 16 | 0 | 0 | 16 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 15 | 0 | 0 | 15 |
| ATAD5 protein, partial | 8 | 0 | 0 | 8 |
| Fumarate hydratase | 6 | 0 | 0 | 6 |
| GLI family zinc finger 3 | 18 | 0 | 0 | 18 |
| caspase 7, apoptosis-related cysteine protease | 9 | 0 | 0 | 9 |
| nuclear receptor subfamily 1, group I, member 3 | 20 | 0 | 0 | 20 |
| progesterone receptor | 16 | 0 | 0 | 16 |
| retinoic acid nuclear receptor alpha variant 1 | 28 | 0 | 0 | 28 |
| retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
| farnesoid X nuclear receptor | 18 | 0 | 0 | 18 |
| pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
| polyprotein | 6 | 0 | 0 | 6 |
| 67.9K protein | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 16 | 0 | 0 | 16 |
| caspase-3 | 9 | 0 | 0 | 9 |
| IDH1 | 9 | 0 | 0 | 9 |
| aryl hydrocarbon receptor | 19 | 0 | 0 | 19 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 21 | 0 | 0 | 21 |
| Histone H2A.x | 10 | 0 | 0 | 10 |
| cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| histone deacetylase 9 isoform 3 | 11 | 0 | 0 | 11 |
| heat shock protein beta-1 | 10 | 0 | 0 | 10 |
| mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
| urokinase-type plasminogen activator precursor | 6 | 0 | 0 | 6 |
| plasminogen precursor | 6 | 0 | 0 | 6 |
| urokinase plasminogen activator surface receptor precursor | 6 | 0 | 0 | 6 |
| geminin | 25 | 0 | 0 | 25 |
| Vif | 0 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 12 | 0 | 0 | 12 |
| survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
| muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 12 | 0 | 12 |
| Multidrug resistance-associated protein 4 | 0 | 12 | 0 | 12 |
| Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
| Bile salt export pump | 0 | 17 | 0 | 17 |
| Interferon beta | 17 | 0 | 0 | 17 |
| Integrin beta-3 | 6 | 1 | 0 | 7 |
| Integrin alpha-IIb | 6 | 1 | 0 | 7 |
| Methionine aminopeptidase | 0 | 4 | 0 | 4 |
| Glutamate receptor 2 | 13 | 0 | 0 | 13 |
| Fatty-acid amide hydrolase 1 | 1 | 4 | 0 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 13 | 0 | 13 |
| EWS/FLI fusion protein | 14 | 0 | 0 | 14 |
| cytochrome P450 2D6 | 10 | 0 | 0 | 10 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 24 | 0 | 0 | 24 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 8 | 0 | 0 | 8 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 4 | 0 | 0 | 4 |
| lethal factor (plasmid) | 11 | 0 | 0 | 11 |
| Polyphenol oxidase 2 | 0 | 4 | 0 | 5 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 5 | 0 | 5 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
| Spike glycoprotein | 10 | 0 | 2 | 12 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 2 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 14 | 0 | 0 | 14 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 7 | 0 | 0 | 7 |
| thioredoxin reductase | 11 | 0 | 0 | 11 |
| GLS protein | 7 | 0 | 0 | 7 |
| aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 6 | 0 | 0 | 6 |
| peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
| DNA polymerase iota isoform a (long) | 11 | 0 | 0 | 11 |
| DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
| Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 6 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 4 | 0 | 8 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
| Adenosine receptor A1 | 0 | 5 | 0 | 7 |
| Adenosine receptor A2a | 0 | 4 | 0 | 7 |
| Substance-P receptor | 0 | 5 | 0 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 9 | 1 | 10 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 11 | 0 | 0 | 11 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 13 | 1 | 0 | 14 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 9 | 0 | 0 | 9 |
| SMAD family member 3 | 9 | 0 | 0 | 9 |
| estrogen receptor 2 (ER beta) | 11 | 0 | 0 | 11 |
| activating transcription factor 6 | 11 | 0 | 0 | 11 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 14 | 0 | 0 | 14 |
| thyroid hormone receptor beta isoform a | 11 | 0 | 0 | 11 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 4 | 0 | 0 | 4 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 2 |
| GTPase KRas | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 6 |
| Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 8 | 0 | 0 | 8 |
| Histamine H1 receptor | 0 | 4 | 2 | 6 |
| MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
| Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
| Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
| Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| glucose-6-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| SUMO-1 | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
| USP1 protein, partial | 15 | 0 | 0 | 15 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Smad3 | 5 | 0 | 0 | 5 |
| PINK1 | 1 | 0 | 0 | 1 |
| G | 12 | 0 | 0 | 12 |
| Parkin | 4 | 0 | 0 | 4 |
| bromodomain adjacent to zinc finger domain 2B | 10 | 0 | 0 | 10 |
| hexokinase | 0 | 2 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 4 |
| Long-chain-fatty-acid--AMP ligase FadD32 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 8 | 0 | 0 | 8 |
| HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Sporulation initiation phosphotransferase F | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 5 | 0 | 5 |
| Adenosine receptor A3 | 0 | 8 | 0 | 8 |
| Alpha-1B adrenergic receptor | 0 | 8 | 0 | 8 |
| Sporulation kinase A | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
| Acetylcholinesterase | 0 | 5 | 0 | 5 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 7 | 0 | 7 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Mitogen-activated protein kinase 14 | 0 | 5 | 0 | 5 |
| Chitinase | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
| Microtubule-associated protein tau | 11 | 0 | 0 | 12 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| GTP-binding nuclear protein Ran isoform 1 | 4 | 0 | 0 | 4 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| Cholecystokinin receptor type A | 0 | 3 | 0 | 3 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 3 | 0 | 3 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| Collagenase 3 | 0 | 4 | 0 | 4 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase beta | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| 15-lipoxygenase, partial | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit pi | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit delta | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 13 | 0 | 0 | 13 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| GABA theta subunit | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit epsilon | 13 | 0 | 0 | 13 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 1 | 0 | 7 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 9 | 0 | 1 | 10 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
| PPM1D protein | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 9 | 0 | 0 | 9 |
| alpha synuclein, partial | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 4 | 0 | 0 | 4 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 0 | 3 | 2 | 5 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Adenosine receptor A2a | 0 | 6 | 2 | 9 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 4 | 0 | 0 | 4 |
| Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
| Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
| Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
| GALC protein | 3 | 0 | 0 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 2 | 0 | 2 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 2 | 3 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| Histamine H3 receptor | 0 | 1 | 2 | 3 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Albumin | 0 | 1 | 1 | 2 |
| Procathepsin L | 0 | 1 | 2 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 1 | 6 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 3 | 2 | 6 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 0 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 3 | 2 | 6 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 2 |
| Bifunctional epoxide hydrolase 2 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
| Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Lactoylglutathione lyase | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 3 | 0 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
| Phospholipase A-2-activating protein | 0 | 3 | 0 | 3 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, Casein Kinase Ii Subunit Alpha | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| histidine kinase | 0 | 1 | 0 | 1 |
| BRCA1 | 3 | 0 | 0 | 3 |
| WRN | 2 | 0 | 0 | 2 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Neuraminidase | 0 | 5 | 0 | 5 |
| P53 | 3 | 0 | 0 | 3 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| Spike glycoprotein | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| galactokinase | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 5 | 0 | 0 | 5 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
| Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 2 | 0 | 2 |
| Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 2 | 1 | 4 |
| Interstitial collagenase | 0 | 2 | 1 | 3 |
| Glucocorticoid receptor | 0 | 2 | 0 | 3 |
| Cytochrome P450 1A1 | 0 | 4 | 1 | 5 |
| Cytochrome P450 1A2 | 0 | 5 | 0 | 5 |
| Cyclin-dependent kinase 1 | 0 | 2 | 0 | 2 |
| Chemotaxis protein CheA | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Tyrosine-protein kinase Yes | 0 | 2 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 3 | 0 | 3 |
| Stromelysin-1 | 0 | 3 | 0 | 3 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 4 | 2 | 6 |
| Replicase polyprotein 1ab | 0 | 4 | 2 | 6 |
| Alpha-amylase 1A | 0 | 2 | 0 | 2 |
| Sialidase | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase pim-1 | 0 | 2 | 1 | 3 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
| G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Urease subunit alpha | 0 | 4 | 0 | 4 |
| G2/mitotic-specific cyclin-B | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha' | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
| Cyclin-dependent kinase 2 | 0 | 2 | 0 | 2 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
| Cytosol aminopeptidase | 0 | 2 | 0 | 2 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 2 | 0 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 2 | 0 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Alpha-synuclein | 1 | 5 | 0 | 6 |
| Macrophage metalloelastase | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Homeobox protein Nkx-2.5 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 2 | 2 | 4 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 2 | 0 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 4 | 0 | 4 |
| Fatty acid synthase | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 alpha | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
| Death-associated protein kinase 1 | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 10 | 0 | 3 | 0 | 3 |
| Casein kinase II subunit beta | 0 | 3 | 0 | 3 |
| Casein kinase II subunit alpha | 0 | 3 | 0 | 3 |
| Urease subunit beta | 0 | 4 | 0 | 4 |
| Xanthine dehydrogenase/oxidase | 0 | 5 | 0 | 7 |
| Cyclin-dependent kinase 6 | 0 | 2 | 0 | 2 |
| Cyclin-dependent-like kinase 5 | 0 | 2 | 0 | 2 |
| Cyclin homolog | 0 | 2 | 0 | 2 |
| Transcription factor GATA-4 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1B1 | 0 | 4 | 1 | 5 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 3 | 0 | 3 |
| Integrase | 0 | 3 | 0 | 3 |
| Protein polybromo-1 | 0 | 0 | 1 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 3 | 0 | 3 |
| Inositol polyphosphate multikinase | 0 | 2 | 0 | 2 |
| Histone-lysine N-methyltransferase SETD7 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 2 | 0 | 2 |
| Enoyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 3 | 0 | 3 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 3 | 0 | 3 |
| Aurora kinase B | 0 | 2 | 0 | 2 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 1 | 0 | 2 | 0 | 2 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 2 | 2 | 4 |
| NADPH oxidase 4 | 0 | 2 | 0 | 2 |
| Dipeptidyl peptidase 3 | 0 | 2 | 0 | 2 |
| Inositol hexakisphosphate kinase 2 | 0 | 2 | 0 | 2 |
| Short transient receptor potential channel 5 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 1 | 4 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| Sialidase-2 | 0 | 2 | 0 | 2 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
| large T antigen | 0 | 1 | 1 | 2 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| Tumor necrosis factor | 0 | 0 | 1 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Interleukin-2 | 0 | 0 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 2 | 0 | 2 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 5 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Integrin beta | 0 | 0 | 1 | 1 |
| Glycoprotein IIb | 0 | 0 | 1 | 1 |
| Transporter | 0 | 1 | 1 | 3 |
| Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
| NADPH oxidase 1 | 0 | 1 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
| Histamine H2 receptor | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
| NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Arginase | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 1 | 2 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Protein E6 | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
| Hepatocyte growth factor receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Chymotrypsinogen B | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
| Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 2 | 0 | 2 |
| Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
| Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| ELAV-like protein 3 | 0 | 1 | 0 | 1 |
| ELAV-like protein 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
| Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
| Chymotrypsin-C | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 2 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
| Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |